Methods and compositions for contributing to the treatment of cancers
AssigneesSpectrum Pharmaceuticals, Inc., The Board of Trustees of the University of Illinois
InventorsAnil Gulati, Guru Reddy, Luigi Lenaz
Life of this patent
Estimating the term…
Abstract
Methods and compositions for contributing to the treatment of cancers, especially ovarian tumors, are disclosed. The methods and compositions utilize an endothelin B agonist (ETB) to enhance the delivery and resulting efficacy of chemotherapeutic agent(s) (e.g., cisplatin and/or cyclophosphamide).
Claims11
A method of contributing to the treatment of cancer comprising administering an endothelin B (ETB) receptor agonist and a chemotherapeutic agent;
- wherein said ETB receptor agonist consists of IRL 1620, and wherein said cancer is an ovarian tumor.
A composition comprising at least one chemotherapeutic agent, IRL-1620, and an optional excipient.
Dependencies are inferred from the claim text.